Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,138.8
-0.2 (-0.01%)

 

  • STI Straits Times Index
    3,138.8
    -0.2 (-0.01%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,514.6
    2.1 (0.14%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,086.4
    -1,105.9 (-4.22%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,381.2
    -86.3 (-2.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,970.2
    136.9 (0.49%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,097.0
    -9.3 (-0.15%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,301.7M
  • Value: 1,151.7M
  • Rise: 136
  • Fall: 216
  • Unch: 409

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.109+0.005
HPH Trust USD0.225-
RH PetroGas0.171-0.002
SingMyanmar^0.141+0.006
YZJ Shipbldg SGD1.390+0.010
Jiutian Chemical0.084-
Mercurius0.062-0.001
GKE0.159-0.001
Genting Sing0.810-
SingPost0.660-0.020

World Indices

World Indices
Name Last Change
Nasdaq 14,660.6 -180.1
HSI 25,086.4
HSCEI 8,879.6
Jakarta 6,097.0
Nikkei 225 27,970.2
SSE Comp 3,381.2
Shanghai A 3,543.7
Shanghai B 256.9
KOSPI 3,232.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AGEX THERAPEUTICS INC AGEX THERAPEUTICS
Updated on 26 Jul 2021 (End of trading day)
Last (USD): 1.330 Change: -0.170 High: 1.550 Remarks: -
Change (%): -11.33 Low: 1.320
Open 1.550 Yesterday's Close 1.5
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 86,126 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.28641 Trailing EPS (USD) e -0.25744 NAV (USD) b -0.1598
PE a - Trailing PE f - Price / NAV b -8.3229
Dividend (USD) d - Cash In Hand (USD) g 0.0213 Issued & Paid-up Shares c 37,935,100
Dividend Yield (%) d - Price / Cash In Hand g 62.441 Treasury Shares h -
Market Cap (M) 50.454 Enterprise Value (M) 56.958
Piotroski F Score 1 Exchange Code AGE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 142.11 Free Float (%) 56.4
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 01 Apr 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Nov 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AGEX THERAPEUTICS INC NYSE American 50.454 - - -8.3229 -
Industry Pharmaceuticals: Major NYSE American 500.064 - - 231.3453 -
Local Peer BROOKLYN IMMUNO THERAPEUTICS INC NYSE American 1,229.838 - - -278.0105 -
Local Peer ANNOVIS BIO INC NYSE American 910.042 - - 208.3136 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 274.114 - - 14.5807 -
Local Peer TIMBER PHARMACEUTICALS INC NYSE American 35.874 - - -19.0922 -
Global Peer JOHNSON & JOHNSON NYSE 452,602.458 30.760 25.474 - 2.315
Global Peer ELI LILLY AND COMPANY NYSE 233,244.713 37.658 38.284 33.8102 1.214
Global Peer PFIZER INC NYSE 234,039.419 24.339 21.102 3.4107 3.639
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 221,434.843 27.270 24.620 4.0975 2.119
Global Peer ABBVIE INC NYSE 208,043.054 45.664 40.921 15.1746 4.106
Global Peer MERCK & CO INC NYSE 195,576.314 27.675 27.828 7.2584 3.208
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 175,948.482 54.628 43.938 12.1932 2.044
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 158,236.431 24.556 23.538 17.1176 1.507
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 151,214.722 - - 4.0211 2.731
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,188.659 9.274 9.274 1.6889 2.596
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), HANSOH PHARMA (HKEx), VIATRIS INC (NASDAQ), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), REPLIGEN CORP (NASDAQ), CUREVAC NV (NASDAQ), SINOPHARM (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), HUTCHMED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), JUNSHI BIO (HKEx), SH PHARMA (HKEx), REMEGEN-B (HKEx), HYGEIA HEALTH (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), CMS (HKEx), AKESO-B (HKEx), INNOCARE-B (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), BAIYUNSHAN PH (HKEx), ALLAKOS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CHINARES PHARMA (HKEx), SIMCERE PHARMA (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), TRAD CHI MED (HKEx), NEKTAR THERAPEUTICS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CHINAGRANDPHARM (HKEx), IGM BIOSCIENCES INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), CSTONE PHARMA-B (HKEx), HENLIUS (HKEx), EVEREST MED-B (HKEx), ERASCA INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), CARSGEN-B (HKEx), SSY GROUP (HKEx), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HEPALINK (HKEx), OCUMENSION-B (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), ZYMEWORKS INC (NYSE), Y-MABS THERAPEUTICS INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANTENGENE-B (HKEx), UNITED LAB (HKEx), NRX PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), TONGRENTANGCM (HKEx), REPARE THERAPEUTICS INC (NASDAQ), Kimia Farma Tbk. (IDX), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), GENERATION BIO CO (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), IMMUNOTECH-B (HKEx), SILVERBACK THERAPEUTICS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), SCICLONE PHARMA (HKEx), PETIQ INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), CKLIFE SCIENCES (HKEx), OLEMA PHARMACEUTICALS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), GH RESEARCH PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), SHINEWAY PHARM (HKEx), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), ANNEXON INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ZHAOKE OPHTH-B (HKEx), EVOLUS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), VERU INC (NASDAQ), AC IMMUNE SA (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), HUA MEDICINE-B (HKEx), KALVISTA PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), Soho Global Health Tbk. (IDX), PHARVARIS NV (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), IGBB (Bursa), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), RACE ONCOLOGY LTD (ASX), PROVENTION BIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), BEYONDSPRING INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), GRITSTONE BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), ATHENEX INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), DAWNRAYS PHARMA (HKEx), 89BIO INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), FUSION PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), IMPEL NEUROPHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), PHARMA (Bursa), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VINCERX PHARMA INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), FUSEN PHARM (HKEx), MUSTANG BIO INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), NEXIMMUNE INC (NASDAQ), IMMUNIC INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), IP (SET), LANNETT CO INC (NYSE), ONCTERNAL THERAPEUTICS INC (NASDAQ), CH BIOTECH SER (HKEx), TYME TECHNOLOGIES INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), POLYPID LTD (NASDAQ), IMARA INC (NASDAQ), ZHONGZHIPHARM (HKEx), VYNE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), NOXOPHARM LTD (ASX), LOGICBIO THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), AQUESTIVE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), NOVAN INC (NASDAQ), IX Biopharma (SGX), ENTERA BIO LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), CRESO PHARMA LTD (ASX), GALECTO INC (NASDAQ), Merck Tbk. (IDX), MEDIWOUND LTD (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), APTORUM GROUP LIMITED (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), KOTRA (Bursa), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), Phapros Tbk. (IDX), DARE BIOSCIENCE INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), Hyphens Pharma (SGX), EDESA BIOTECH INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MODERN CHI MED (HKEx), NOVA (Bursa), EXOPHARM LTD (ASX), BIOHLDG (Bursa), INHIBIKASE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), NEP INTERLONG (HKEx), ASSERTIO HOLDINGS INC (NASDAQ), INVION LTD (ASX), BAUDAX BIO INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), WAI YUEN TONG (HKEx), VIRIOS THERAPEUTICS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), CNS PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PALLA PHARMA LTD (ASX), TELIGENT INC NEW (NASDAQ), TBG DIAGNOSTICS LTD (ASX), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), PAINREFORM LTD (NASDAQ), PURAPHARM (HKEx), ONCOSIL MEDICAL LIMITED (ASX), ACER THERAPEUTICS INC (NASDAQ), SANAI HEALTH GP (HKEx), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), EXTRAWELL PHAR (HKEx), HOTH THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), JCT (SET), SUNZEN (Bursa), PETROS PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), ACRUX (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), IMMURON LIMITED (ASX), TALI DIGITAL LIMITED (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.170
-11.33 %
10 Days -+0.030
+2.31 %
20 Days --0.350
-20.83 %
Medium Term Return 3 Months --0.090
-6.34 %
6 Months --0.520
-28.11 %
1 Year -+0.100
+8.13 %
Long Term Return 2 Years --1.430
-51.81 %
Annualised Return Annualised --
-30.58 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.750 - 3.930 Change From 1 Year Low +0.580 % Change From 1 Year Low (%) +77.31
Change From 1 Year High -2.600 % Change From 1 Year High (%) -66.16
2 Years Range 0.666 - 3.930 Change From 2 Years Low +0.664 % Change From 2 Years Low (%) +99.70
Change From 2 Years High -2.600 % Change From 2 Years High (%) -66.16
5 Years Range 0.666 - 5.950 Change From 5 Years Low +0.664 % Change From 5 Years Low (%) +99.70
Change From 5 Years High -4.620 % Change From 5 Years High (%) -77.65
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR, and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Jul 2021 1.550 1.550 1.320 1.330 86,126 -
23 Jul 2021 1.490 1.540 1.400 1.500 101,328 -
22 Jul 2021 1.520 1.550 1.504 1.530 33,579 -
21 Jul 2021 1.530 1.560 1.500 1.540 97,773 -
20 Jul 2021 1.550 1.550 1.470 1.500 95,640 -
19 Jul 2021 1.450 1.520 1.380 1.520 79,796 -
16 Jul 2021 1.420 1.490 1.390 1.470 97,997 -
15 Jul 2021 1.460 1.470 1.410 1.450 30,001 -
14 Jul 2021 1.380 1.470 1.340 1.460 97,280 -
13 Jul 2021 1.410 1.427 1.290 1.300 133,607 -
12 Jul 2021 1.480 1.490 1.410 1.410 45,899 -
09 Jul 2021 1.460 1.500 1.450 1.490 42,405 -
08 Jul 2021 1.400 1.570 1.400 1.520 103,168 -
07 Jul 2021 1.450 1.490 1.410 1.444 42,267 -
06 Jul 2021 1.600 1.639 1.411 1.490 53,915 -
02 Jul 2021 1.490 1.520 1.410 1.440 43,444 -
01 Jul 2021 1.550 1.550 1.500 1.520 75,433 -
30 Jun 2021 1.650 1.710 1.540 1.550 70,863 -
29 Jun 2021 1.700 1.710 1.620 1.680 88,794 -
28 Jun 2021 1.650 1.690 1.600 1.680 94,514 -
25 Jun 2021 1.480 1.650 1.460 1.650 202,852 -
24 Jun 2021 1.420 1.490 1.420 1.480 21,586 -
Summary
Current 2 Weeks
(13 Jul 2021 to 26 Jul 2021)
1.410 1.560 1.290 1.330 853,127 -
Previous 2 Weeks
(28 Jun 2021 to 12 Jul 2021)
1.650 1.690 1.290 1.410 660,702 -
4 Weeks from
(28 May 2021 to 25 Jun 2021)
1.250 1.560 1.250 1.650 1,998,536 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.